Iffa Jayyana

Strengthening Resilience: WHO Director-General’s State Visit to Jordan Highlights Global Health Leadership and Humanitarian Solidarity

• Breast Cancer Prevention and Lifestyle

Strengthening Resilience: WHO Director-General’s State Visit to Jordan Highlights Global Health Leadership and Humanitarian Solidarity

Iffa Jayyana October 12, 2026

AMMAN, Jordan – The World Health Organization (WHO) Director-General, Dr. Tedros Adhanom Ghebreyesus, has concluded the first...

Read More Read more about Strengthening Resilience: WHO Director-General’s State Visit to Jordan Highlights Global Health Leadership and Humanitarian Solidarity

HudsonAlpha Launches "The Primer Lab": A New Engine for Alabama’s Biotech Evolution

• Genomics and Precision Medicine

HudsonAlpha Launches "The Primer Lab": A New Engine for Alabama’s Biotech Evolution

Iffa Jayyana October 12, 2026

HUNTSVILLE, AL – In a strategic move to solidify Alabama’s position as a premier global destination for...

Read More Read more about HudsonAlpha Launches "The Primer Lab": A New Engine for Alabama’s Biotech Evolution

First Tracks Gains Momentum: Promising Early Data for Celiac Drug ANB033 Signals Breakthrough in Autoimmune Therapeutics

• Chemotherapy and Targeted Therapy

First Tracks Gains Momentum: Promising Early Data for Celiac Drug ANB033 Signals Breakthrough in Autoimmune Therapeutics

Iffa Jayyana October 12, 2026

By Delilah Alvarado Published October 12, 2026 In a landscape dominated by strict dietary restrictions and a...

Read More Read more about First Tracks Gains Momentum: Promising Early Data for Celiac Drug ANB033 Signals Breakthrough in Autoimmune Therapeutics

Unveiling a Master Manipulator: How Aggressive Breast Cancer Hijacks the Immune System to Grow Nerves and Fuel Its Spread

• Medical Research and Clinical Trials

Unveiling a Master Manipulator: How Aggressive Breast Cancer Hijacks the Immune System to Grow Nerves and Fuel Its Spread

Iffa Jayyana October 11, 2026

Oklahoma City, OK – In a groundbreaking discovery that redefines our understanding of cancer progression, new research...

Read More Read more about Unveiling a Master Manipulator: How Aggressive Breast Cancer Hijacks the Immune System to Grow Nerves and Fuel Its Spread

The Digital Renaissance of Pathology: Mining Archives to Redefine Preclinical Research

• Chemotherapy and Targeted Therapy

The Digital Renaissance of Pathology: Mining Archives to Redefine Preclinical Research

Iffa Jayyana October 11, 2026

In the landscape of modern drug discovery, a profound shift is occurring beneath the lens of the...

Read More Read more about The Digital Renaissance of Pathology: Mining Archives to Redefine Preclinical Research

FDA Expands Frontline Arsenal: Tucatinib Combination Approved as Maintenance Therapy for HER2-Positive Metastatic Breast Cancer

• Patient Advocacy and Support

FDA Expands Frontline Arsenal: Tucatinib Combination Approved as Maintenance Therapy for HER2-Positive Metastatic Breast Cancer

Iffa Jayyana October 11, 2026

The landscape of metastatic breast cancer (MBC) treatment has undergone a significant transformation with the recent U.S....

Read More Read more about FDA Expands Frontline Arsenal: Tucatinib Combination Approved as Maintenance Therapy for HER2-Positive Metastatic Breast Cancer

FDA Expands First-Line Maintenance Options for HER2-Positive Metastatic Breast Cancer: A New Era of Targeted Triple Therapy

• Patient Advocacy and Support

FDA Expands First-Line Maintenance Options for HER2-Positive Metastatic Breast Cancer: A New Era of Targeted Triple Therapy

Iffa Jayyana October 10, 2026

In a landmark decision that promises to reshape the standard of care for patients battling advanced malignancy,...

Read More Read more about FDA Expands First-Line Maintenance Options for HER2-Positive Metastatic Breast Cancer: A New Era of Targeted Triple Therapy

Legal Tensions in Electrophysiology: Boston Scientific Targets J&J Subsidiary in High-Stakes Patent Dispute

• Treatment Innovations

Legal Tensions in Electrophysiology: Boston Scientific Targets J&J Subsidiary in High-Stakes Patent Dispute

Iffa Jayyana October 10, 2026

The competitive landscape of cardiac electrophysiology—a field characterized by rapid technological advancement and high-value acquisitions—has been disrupted...

Read More Read more about Legal Tensions in Electrophysiology: Boston Scientific Targets J&J Subsidiary in High-Stakes Patent Dispute

Navigating the Nexus: GLP-1 Medications and Breast Cancer – Unpacking the Latest Insights

• Patient Advocacy and Support

Navigating the Nexus: GLP-1 Medications and Breast Cancer – Unpacking the Latest Insights

Iffa Jayyana October 10, 2026

By Douglas Feil, NBCF Chief Program Officer The landscape of medical treatment is constantly evolving, and recent...

Read More Read more about Navigating the Nexus: GLP-1 Medications and Breast Cancer – Unpacking the Latest Insights

A New Standard in Metastatic Care: FDA Approves Tucatinib Combination as First-Line Maintenance for HER2-Positive Breast Cancer

• Patient Advocacy and Support

A New Standard in Metastatic Care: FDA Approves Tucatinib Combination as First-Line Maintenance for HER2-Positive Breast Cancer

Iffa Jayyana October 10, 2026

Introduction In a significant advancement for the oncology community and thousands of patients nationwide, the U.S. Food...

Read More Read more about A New Standard in Metastatic Care: FDA Approves Tucatinib Combination as First-Line Maintenance for HER2-Positive Breast Cancer